Arandomized phase 3 trial of thalidomide and prednisone as maintenance therapy afterASCT in patients withMMwith a quality-of-life assessment: The national cancer Institute of Canada clinicals trials group myeloma 10 trial

A. Keith Stewart, Suzanne Trudel, Nizar J. Bahlis, Darrell White, Waleed Sabry, Andrew Belch, Tony Reiman, Jean Roy, Chaim Shustik, Michael J. Kovacs, Morel Rubinger, Guy Cantin, Kevin Song, Kirsty A. Tompkins, Deb C. Marcellus, Martha Q. Lacy, Jonathan Sussman, Donna Reece, Michael Brundage, Erica L. HarnettLois Shepherd, Judy Anne W. Chapman, Ralph M. Meyer

Research output: Contribution to journalArticle

100 Scopus citations

Fingerprint Dive into the research topics of 'Arandomized phase 3 trial of thalidomide and prednisone as maintenance therapy afterASCT in patients withMMwith a quality-of-life assessment: The national cancer Institute of Canada clinicals trials group myeloma 10 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds